Mounjaro Weight Loss Dosages: A Complete Guide

Most Mounjaro dosing guides stop at "start low, go slow." This one has the actual numbers: the exact escalation ladder from the prescribing information, what each dose delivered in the SURMOUNT-1 trial, how clinicians decide between holding a dose and moving up, and the label's missed-dose rules. Revised September 2026 with the per-dose trial data.

First, the naming problem: Mounjaro vs Zepbound

Mounjaro and Zepbound are the same molecule — tirzepatide — made by the same company. Mounjaro is FDA-approved for type 2 diabetes; Zepbound is the brand FDA-approved for chronic weight management, approved in late 2023. Using Mounjaro specifically for weight loss is off-label, which matters mostly for insurance: many plans cover one brand and not the other, and prior authorizations are written against the indication. The dosing schedule below is identical for both brands, so everything here applies whichever box your pen comes in.

The escalation ladder, exactly as the label writes it

The prescribing information is stricter than most summaries suggest. Three rules define the whole schedule:

1. Everyone starts at 2.5 mg once weekly. The starting dose exists to let your gut adapt, not to produce much effect on its own.
2. You may only increase in 2.5 mg steps, and only after at least 4 weeks on the current dose. No skipping rungs, no moving up at week 2 because you feel fine.
3. 15 mg once weekly is the maximum. There is no labeled dose above it.

The fastest possible path to 15 mg is therefore 20 weeks — five rungs, four weeks each. Most people move more slowly, and that is normal, not failure. Each rung has its own deep-dive on this site: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg.

What each dose actually delivered in SURMOUNT-1

The pivotal weight-loss trial (Jastreboff et al., NEJM 2022) randomized 2,539 adults with obesity, without diabetes, to tirzepatide 5, 10, or 15 mg or placebo for 72 weeks. The results are the clearest answer to "what does each step buy me?":

Two patterns in this table drive real-world dosing decisions. First, the jump from 5 mg to 10 mg is large (−15.0% to −19.5%), while 10 mg to 15 mg adds about a point and a half — diminishing returns near the top of the ladder. Second, side-effect-driven dropouts roughly track dose, which is why the schedule insists on four-week steps. The most common adverse events were gastrointestinal, mostly mild to moderate, and occurred primarily during dose escalation — the weeks right after moving up are the hard part, not the months after.

Hold or escalate: how the decision actually works

The label gives the schedule, but it deliberately leaves the pace to the prescriber. In practice, the hold-or-escalate conversation at each four-week mark usually weighs three things:

• Tolerability comes first. If nausea, vomiting, or diarrhea are still disruptive, you hold — escalating into active side effects is how people end up quitting a medication that was working. Our guides on managing nausea on Mounjaro and foods to avoid on Mounjaro cover the usual mitigation playbook.
• A plateau means weeks, not days. Weight fluctuates by a kilogram or more with water and gut contents. A stall shorter than three to four weeks is usually noise; escalating in response to a single flat week burns a rung of the ladder you may want later.
• The goal is the lowest dose that keeps working, not 15 mg. If you are still losing steadily at 5 or 10 mg, there is no requirement to move up. Given the diminishing returns above 10 mg in SURMOUNT-1, "highest tolerated, lowest effective" is a reasonable summary of how many clinicians approach it.

Tracking your doses, weight, and side effects week by week makes this conversation dramatically more productive — you and your prescriber are looking at a curve instead of a feeling. The Mounjaro tracker and our titration schedule guide are built for exactly that.

Missed doses: the 96-hour rule

The label's rule is simple: if you miss a dose, take it as soon as possible within 4 days (96 hours) of the missed dose. If more than 4 days have passed, skip it entirely and take the next dose on your regular day — never double up to catch up. One practical detail people learn the hard way: after several weeks off, your gut has de-adapted, and restarting at your old dose can bring back the week-one nausea. If you have missed more than a dose or two, ask your prescriber whether to restart at a lower rung rather than jumping back in at full strength.

Why the side effects cluster where they do

Tirzepatide slows gastric emptying, and that effect is felt hardest when the dose changes. This is why the label-mandated four-week steps exist, why the first days after an escalation are when nausea, diarrhea, and vomiting show up, and why most people report the second month on a given dose is far easier than the first. Knowing the pattern in advance turns "something is wrong" into "this is the expected week."

FAQ

How long does it take to reach 15 mg on Mounjaro?

At the fastest label-compliant pace, 20 weeks: 2.5 mg for four weeks, then a 2.5 mg step every four weeks. Many people take longer, holding at intermediate doses for months — and many never need the top rung at all.

Can I just stay on 2.5 mg or 5 mg?

The distinction matters: 5 mg is the first rung the labels treat as a maintenance dose, and holding at 5 mg — or any later rung that keeps appetite quiet and weight trending down — is a common, label-consistent choice to make with your prescriber. The 2.5 mg starter is different: it exists for adaptation, most of the trial-measured effect begins at 5 mg, and Zepbound's label states outright that 2.5 mg is for treatment initiation and is not approved as a maintenance dose. So yes, many people stay at a low dose long-term — but the low dose in question is 5 mg, not the starter.

Is Mounjaro dosing different from Zepbound dosing?

No — same molecule, same 2.5 mg-step schedule, same 15 mg ceiling. The differences are the approved indication, the box, and what your insurance will pay for. See our Mounjaro vs Zepbound comparison for the full picture.

What if 15 mg stops working?

There is no labeled dose above 15 mg, so "go higher" is not an option. At that point the conversation with your prescriber shifts to adherence, diet and activity, how long the stall has lasted, and whether a different medication class makes sense — not to squeezing more out of the same pen.

Key takeaways

• The ladder is fixed: 2.5 mg start, 2.5 mg steps, at least four weeks apart, 15 mg maximum — for both Mounjaro and Zepbound.
• In SURMOUNT-1, mean weight loss at 72 weeks was −15.0% (5 mg), −19.5% (10 mg), and −20.9% (15 mg) versus −3.1% on placebo; the biggest single gain comes from reaching 10 mg.
• Escalate only when you tolerate the current dose and progress has genuinely stalled for weeks — the goal is the lowest dose that keeps working.
• Missed a dose? You have 96 hours. Past that, skip and never double up.

References

1. FDA. Mounjaro (tirzepatide) injection — Prescribing Information (DailyMed, current label)
2. Jastreboff AM, et al. "Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1)." N Engl J Med. 2022;387(3):205-216
3. FDA. "FDA Approves New Medication for Chronic Weight Management" (Zepbound approval). 2023

Disclaimer: This guide is informational and is not medical advice. Dosing decisions belong to you and your prescriber — never start, stop, or change a dose without them.